Evidence map›Paper›PMID 20829501›Full record

ArticleJournal of applied physiology (Bethesda, Md. : 1985)2010

ATP and the purine type 2 X7 receptor affect sleep.

James M Krueger, Ping Taishi, Alok De, Christopher J Davis, Bradley D Winters, James Clinton, Eva Szentirmai, Mark R Zielinski

Open access · greenAbstract read
In one paragraph

Article in Journal of applied physiology (Bethesda, Md. : 1985), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Microglial Regulation of Sleep and Wakefulness.Advances in neurobiology · 2024
    Review
  5. Tripping on the edge of consciousness.Sleep advances : a journal of the Sleep Research Society · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Sleep, Narcolepsy, and Sodium Oxybate.Current neuropharmacology · 2022
    Article
  10. Neuroinflammation, Sleep, and Circadian Rhythms.Frontiers in cellular and infection microbiology · 2022
    Review
  11. Article
  12. Review
  13. Review
  14. Sleep deprivation, vigilant attention, and brain function: a review.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Heterozygosity for the Mood Disorder-Associated Variant Gln460Arg Alters P2X7 Receptor Function and Sleep Quality.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

James M KruegerSleep and Performance Research Center, Programs in Neuroscience, Dept. of Veterinary and Comparative Anatomy, Pharmacology, and Physiology, College of Veterinary Medicine, Washington State University, Pullman, WA 99164-6520, USA. krueger@vetmed.wsu.edu
Ping Taishi
Alok De
Christopher J Davis
Bradley D Winters
James Clinton
Eva Szentirmai
Mark R Zielinski
Washington State University · US

Funding

INTERLEUKIN-1--PROMOTER OF SLOW-WAVE SLEEPR01NS025378 · NINDS · WASHINGTON STATE UNIVERSITY · PI KRUEGER, JAMES MARTIN · 1987 to 2020
$6.3M
SLEEP REGULATION AND TUMOR NECROSIS FACTORR01NS031453 · NINDS · WASHINGTON STATE UNIVERSITY · PI KRUEGER, JAMES MARTIN · 1993 to 2011
$3.6M
NINDS NIH HHS NS-25378NINDS NIH HHS NS-31453NINDS NIH HHS R01 NS025378NINDS NIH HHS R01 NS031453
6 · The paper itself

Abstract

Sleep is dependent upon prior brain activities, e.g., after prolonged wakefulness sleep rebound occurs. These effects are mediated, in part, by humoral sleep regulatory substances such as cytokines. However, the property of wakefulness activity that initiates production and release of such substances and thereby provides a signal for indexing prior waking activity is unknown. We propose that extracellular ATP, released during neuro- and gliotransmission and acting via purine type 2 (P2) receptors, is such a signal. ATP induces cytokine release from glia. Cytokines in turn affect sleep. We show here that a P2 receptor agonist, 2'(3')-O-(4-benzoylbenzoyl)adenosine 5'-triphosphate (BzATP), increased non-rapid eye movement sleep (NREMS) and electroencephalographic (EEG) delta power while two different P2 receptor antagonists, acting by different inhibitory mechanisms, reduced spontaneous NREMS in rats. Rat P2X7 receptor protein varied in the somatosensory cortex with time of day, and P2X7 mRNA was altered by interleukin-1 treatment, by sleep deprivation, and with time of day in the hypothalamus and somatosensory cortex. Mice lacking functional P2X7 receptors had attenuated NREMS and EEG delta power responses to sleep deprivation but not to interleukin-1 treatment compared with wild-type mice. Data are consistent with the hypothesis that extracellular ATP, released as a consequence of cell activity and acting via P2 receptors to release cytokines and other sleep regulatory substances, provides a mechanism by which the brain could monitor prior activity and translate it into sleep.

Indexed as

Signal TransductionSleepAdenosine TriphosphateAnimalsBrain WavesCircadian RhythmElectroencephalographyElectromyographyHumansInterleukin-1MaleMiceMice, Inbred C57BLMice, KnockoutPurinergic P2 Receptor AgonistsPurinergic P2 Receptor AntagonistsAdenosine TriphosphateInterleukin-1Purinergic P2 Receptor AgonistsPurinergic P2 Receptor AntagonistsReceptors, Purinergic P2X7Recombinant ProteinsRNA, Messenger

Identifiers

PMID20829501
PMCPMC2980381
OpenAlexW2098990962

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.